Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan (International Journal of Hematology, (2018), 107, 6, (656-665), 10.1007/s12185-018-2409-3)

Yasutaka Ueda, Naoshi Obara, Yuji Yonemura, Hideyoshi Noji, Masayoshi Masuko, Yoshinobu Seki, Katsuya Wada, Takahisa Matsuda, Hirozumi Akiyama, Takayuki Ikezoe, Shigeru Chiba, Yoshinobu Kanda, Tatsuya Kawaguchi, Tsutomu Shichishima, Hideki Nakakuma, Shinichiro Okamoto, Jun ichi Nishimura, Yuzuru Kanakura, Haruhiko Ninomiya

Research output: Contribution to journalComment/debate

Abstract

In the original publication of this article, Tables 2, 3 and 4 were published incorrectly. The corrected tables 2, 3 and 4 are given in the following pages.

Original languageEnglish
Pages (from-to)233-235
Number of pages3
JournalInternational Journal of Hematology
Volume108
Issue number2
DOIs
Publication statusPublished - 2018 Aug 1

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan (International Journal of Hematology, (2018), 107, 6, (656-665), 10.1007/s12185-018-2409-3)'. Together they form a unique fingerprint.

  • Cite this

    Ueda, Y., Obara, N., Yonemura, Y., Noji, H., Masuko, M., Seki, Y., Wada, K., Matsuda, T., Akiyama, H., Ikezoe, T., Chiba, S., Kanda, Y., Kawaguchi, T., Shichishima, T., Nakakuma, H., Okamoto, S., Nishimura, J. I., Kanakura, Y., & Ninomiya, H. (2018). Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan (International Journal of Hematology, (2018), 107, 6, (656-665), 10.1007/s12185-018-2409-3). International Journal of Hematology, 108(2), 233-235. https://doi.org/10.1007/s12185-018-2486-3